Cubro Hajrunisa, Somun-Kapetanovic Rabija, Thiery Guillaume, Talmor Daniel, Gajic Ognjen
Hajrunisa Cubro, Guillaume Thiery, Medical Intensive Care Unit, Sarajevo University Clinical Center, Sarajevo 71000, Bosnia and Herzegovina.
World J Crit Care Med. 2016 May 4;5(2):150-64. doi: 10.5492/wjccm.v5.i2.150.
To calculate cost effectiveness of the treatment of critically ill patients in a medical intensive care unit (ICU) of a middle income country with limited access to ICU resources.
A prospective cohort study and economic evaluation of consecutive patients treated in a recently established medical ICU in Sarajevo, Bosnia and Herzegovina. A cost utility analysis of the intensive care of critically ill patients compared to the hospital ward treatment from the perspective of the health care system was subsequently performed. Incremental cost effectiveness was calculated using estimates of ICU vs non-ICU treatment effectiveness based on a formal systematic review of published studies. Decision analytic modeling was used to compare treatment alternatives. Sensitivity analyses of the key model parameters were performed.
Out of 148 patients, seventy patients (47.2%) survived to one year after critical illness with a median quality of life index 0.64 [interquartile range(IQR) 0.49-0.76]. Median number of life years gained per patient was 30 (IQR 16-40) or 18 quality adjusted life years (QALYs) (IQR 7-28). The cost of treatment of critically ill patients varied between 1820 dollar and 20109 dollar per hospital survivor and between 100 dollar and 2514 dollar per QALY saved. Mean factors that influenced costs were: Age, diagnostic category, ICU and hospital length of stay and number and type of diagnostic and therapeutic interventions. The incremental cost effectiveness ratio for ICU treatment was estimated at 3254 dollar per QALY corresponding to 35% of per capita GDP or a Very Cost Effective category according to World Health Organization criteria.
The ICU treatment of critically ill medical patients in a resource poor country is cost effective and compares favorably with other medical interventions. Public health authorities in low and middle income countries should encourage development of critical care services.
计算在一个重症监护资源有限的中等收入国家的医疗重症监护病房(ICU)中治疗重症患者的成本效益。
对波斯尼亚和黑塞哥维那萨拉热窝一家新建的医疗ICU中连续治疗的患者进行前瞻性队列研究和经济评估。随后从卫生保健系统的角度对重症患者的重症监护与医院病房治疗进行成本效用分析。使用基于对已发表研究的正式系统评价的ICU与非ICU治疗效果估计值来计算增量成本效益。采用决策分析模型比较治疗方案。对关键模型参数进行敏感性分析。
148例患者中,70例(47.2%)在重症疾病后存活至一年,生活质量指数中位数为0.64[四分位间距(IQR)0.49 - 0.76]。每位患者获得的生命年中位数为30(IQR 16 - 40)或18个质量调整生命年(QALY)(IQR 7 - 28)。每位医院幸存者的重症患者治疗成本在1820美元至20109美元之间,每挽救一个QALY的成本在100美元至2514美元之间。影响成本的平均因素有:年龄、诊断类别、ICU和医院住院时间以及诊断和治疗干预的数量和类型。ICU治疗的增量成本效益比估计为每QALY 3254美元,相当于人均GDP的35%,根据世界卫生组织标准属于非常具有成本效益的类别。
在资源匮乏国家,对重症内科患者进行ICU治疗具有成本效益,与其他医疗干预措施相比具有优势。低收入和中等收入国家的公共卫生当局应鼓励发展重症监护服务。